91378-31-3

Basic information

• Product Name: Benzaldehyde, 4-(4-hydroxyphenoxy)-
• CAS NO: 91378-31-3
• Molecular Formula: C13H10O3
• Molecular Weight: 214.221
• Mol File: 91378-31-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-(4-hydroxyphenoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-(4-hydroxyphenoxy)-(91378-31-3)
• EPA Substance Registry System: Benzaldehyde, 4-(4-hydroxyphenoxy)-(91378-31-3)

Safety Data

• Hazardous Substances Data: 91378-31-3(Hazardous Substances Data)

Upstream product

• 459-57-4 4-fluorobenzaldehyde 
• 123-31-9 hydroquinone 
• 78725-47-0 4-(4-methoxyphenoxy)benzaldehyde 
• 1122-91-4 4-bromo-benzaldehyde 
• 123-08-0 4-hydroxy-benzaldehyde 
• 5720-07-0 4-methoxyphenylboronic acid 
• 141-53-7 sodium formate 

Downstream Products

• 1965-09-9 4,4'-dihydroxydiphenyl ether 
• 606966-71-6 hydroxy-(3-{3-[4-(4-hydroxy-phenoxy)-2-propyl-phenoxy]-propoxy}-phenyl)-acetic acid methyl ester 
• 606966-83-0 4-(4-Hydroxy-phenoxy)-2-propyl-phenol 
• 188351-19-1 2-Allyl-4-(4-hydroxy-phenoxy)-phenol 
• 114896-77-4 4-(4-allyloxy-phenoxy)-phenol 

Relevant articles and documents

Oxidative and Reductive Cross-Coupling Reactions Catalyzed by an Anionic "ligandless" Palladium Complex

The anionic complex [NBu4][Pd(DMSO)Cl3], which can be synthesized on a gram scale in a single step starting from commercially available starting materials, has been shown to be an active catalyst in the Mizoroki-Heck reaction of aryl halides. We present two new catalytic applications of this complex: the base-free oxidative Heck reaction and the reductive homodimerization of aryl halides. This complex outperformed other palladium salts. In the latter reaction, the catalyst loading could be reduced to 0.01 mol %. The scope of the reactions has been explored, demonstrating the potential of the anionic palladium complex in these catalytic transformations.

Discovery of orally available spirodiketopiperazine-based CCR5 antagonists

Using the previously reported novel spirodiketopiperazine scaffold, the design and synthesis of orally available CCR5 antagonists was undertaken. Compounds possessing a carboxylic acid function in the appropriate position showed improved oral exposure (AU

Cyclodienones. X. Reaction of Halo-cyclohexadien-1-ones with Phenols in the Presence of α-Picoline and Preparation of 4-Hydroxy- and 2-Hydroxyphenyl Aryl Ethers

Reaction of 4-halocyclohexadienones such as 4-bromo-(1a), 4-chloro-2,4,6-tri-t-butyl-(1b), 2,4-dichloro-4,6-di-t-butyl-2,5-cyclohexadien-1-one, and 2,4-dichloro-2,6-di-t-butyl-3,5-cyclohexadien-1-one with phenols in the presence of α-picoline was carried out under various conditions.The reaction of 1a and 1b with phenols afforded the corresponding 2-aryloxy-4,6-di-t-butyl phenols together with various by-products.The AlCl3 catalyzed trans-t-butylation of 2-aroxy-4,6-di-t-butyl-phenols, which were obtained by the above reaction, afforded the corresponding 2-hydroxyphenyl aryl ethers.The similar reaction of 4-aroxy-2,4,6-tri-t-butyl-2,5-cyclohexadien-1-ones also afforded the corresponding 4-hydroxyphenyl aryl ethers.